The Event
Â
Bangalore INDIA BIO is an annual event organized by Department of IT, BT and S & T, Government of Karnataka, under the guidance of Vision Group on Biotechnology, an apex advisory body comprising of members from Government, Public and Private Sectors including Industry and Academia. Since 2001, Bangalore INDIA BIO has been instrumental in promoting the inherent strength of the Indian Biotech Industry to the outside world and is now acknowledged as the biggest and Indias National event on Life Sciences.
The potential of Biotechnology sector is tremendous and the vision of Department of Biotechnology and the Biotech Industry is to achieve a size of US$ 100b by 2025. Indias Biotechnoloygy sector has grown steadily over the last decade from US$ 500m in 2003 to US$ 4b in 2014 - 15. Today Indian Biotech stands 4th in term of volume and 13th in terms of value, holding 2% of global Biotech industry share.
The theme of Bangalore INDIA BIO 2016 is "Whats Trending in Biotech India" and is expected to attract participation from Global Biotech Fraternity.
Â
>> | 3rd biggest biotech industry in the Asia-Pacific region. |
>> | 2nd highest number of USFDA–approved plants. |
>> | USD 3.7 Billion to be spent on biotechnology from 2012-17. |
>> | No. 1 producer of Hepatitis B vaccine recombinant. |
>> | USD 100 Billion industry by 2025. |
Â
>> | India is amongst the top 12 biotech destinations in the world and ranks third in the Asia-Pacific region. |
>> | India has the second-highest number of USFDA–approved plants, after the USA. |
>> | India adopted the product patent regime in 2005. |
>> | Increasing government expenditure will augment the growth of the sector - the government aims to spend USD 3.7 Billion on biotechnology between 2012-17. |
>> | India is the largest producer of recombinant Hepatitis B vaccine. |
>> | India has the potential to become a major producer of transgenic rice and several genetically modified (GM) or engineered vegetables |